These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 26232338

  • 1. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.
    Nymoen DA, Hetland Falkenthal TE, Holth A, Ow GS, Ivshina AV, Tropé CG, Kuznetsov VA, Staff AC, Davidson B.
    Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma.
    Nymoen DA, Holth A, Hetland Falkenthal TE, Tropé CG, Davidson B.
    Mol Cancer; 2015 Feb 18; 14():44. PubMed ID: 25889687
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.
    Vaksman O, Hetland TE, Trope' CG, Reich R, Davidson B.
    Hum Pathol; 2012 Nov 18; 43(11):2062-9. PubMed ID: 22647351
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance.
    Hetland TE, Nymoen DA, Holth A, Brusegard K, Flørenes VA, Kærn J, Tropé CG, Davidson B.
    Hum Pathol; 2013 May 18; 44(5):777-85. PubMed ID: 23114921
    [Abstract] [Full Text] [Related]

  • 11. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
    Karbova E, Davidson B, Metodiev K, Tropé CG, Nesland JM.
    Int J Surg Pathol; 2002 Jul 18; 10(3):175-80. PubMed ID: 12232570
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
    Davidson B, Trope' CG, Wang TL, Shih IeM.
    Gynecol Oncol; 2006 Dec 18; 103(3):814-9. PubMed ID: 16844205
    [Abstract] [Full Text] [Related]

  • 15. BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.
    Davidson B, Nymoen DA, Elgaaen BV, Staff AC, Tropé CG, Kærn J, Reich R, Falkenthal TE.
    Virchows Arch; 2014 Jun 18; 464(6):701-7. PubMed ID: 24756216
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.